Anthony S Wierzbicki Selected Research

Creatine Kinase (Creatine Phosphokinase)

3/2012	Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
3/2005	Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony S Wierzbicki Research Topics

Disease

35	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 07/2003
19	Coronary Disease (Coronary Heart Disease) 07/2015 - 01/2002
15	Atherosclerosis 01/2020 - 07/2002
9	Inflammation (Inflammations) 01/2022 - 07/2003
9	Insulin Resistance 01/2022 - 05/2002
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2017 - 08/2008
7	Pancreatitis 04/2023 - 07/2009
7	Refsum Disease (Refsum's Disease) 01/2017 - 03/2002
7	Stroke (Strokes) 12/2015 - 05/2002
6	Hypertension (High Blood Pressure) 01/2021 - 07/2002
4	Rare Diseases (Rare Disease) 12/2022 - 01/2013
4	Hypercholesterolemia 08/2022 - 07/2004
4	Muscular Diseases (Myopathy) 12/2019 - 11/2009
4	Type 2 Diabetes Mellitus (MODY) 02/2019 - 12/2006
4	Heart Diseases (Heart Disease) 07/2017 - 11/2005
4	HIV Infections (HIV Infection) 07/2014 - 11/2005
4	Hypertriglyceridemia 04/2012 - 01/2002
3	Rhabdomyolysis 11/2017 - 09/2003
3	Neoplasms (Cancer) 07/2017 - 03/2002
3	Lipodystrophy 01/2016 - 11/2005
3	Non-alcoholic Fatty Liver Disease 07/2014 - 08/2012
3	Erectile Dysfunction 07/2014 - 04/2006
3	Dyslipidemias (Dyslipidemia) 08/2013 - 01/2006
3	Atherosclerotic Plaque (Atheroma) 02/2013 - 07/2003
3	Weight Loss (Weight Reduction) 08/2012 - 01/2010
3	Vascular Diseases (Vascular Disease) 07/2012 - 07/2008
2	Costello Syndrome 01/2023 - 01/2020
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2020 - 01/2017
2	Acute Coronary Syndrome 01/2018 - 10/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 07/2013
2	Body Weight (Weight, Body) 01/2017 - 07/2003
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2014 - 08/2013
2	Homozygous Familial Hypercholesterolemia 09/2013 - 01/2011
2	Chronic Renal Insufficiency 08/2013 - 07/2013
2	Obesity 07/2013 - 09/2007
2	Carotid Artery Diseases 07/2013 - 07/2012
2	Xanthomatosis (Xanthoma) 02/2013 - 03/2006
2	Carotid Stenosis (Carotid Artery Stenosis) 07/2012 - 03/2007
2	Ataxia (Dyssynergia) 11/2010 - 03/2002
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2010 - 05/2002
2	Thrombosis (Thrombus) 07/2008 - 07/2003
2	Osteoporosis 01/2004 - 03/2002
2	Deafness (Deaf Mutism) 09/2003 - 03/2002
2	Peroxisomal Disorders (Peroxisomal Disorder) 02/2003 - 03/2002
1	Hyperglycemia 08/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 08/2022
1	Gaucher Disease (Gaucher's Disease) 09/2021

Drug/Important Bio-Agent (IBA)

35	LipidsIBA 08/2022 - 03/2002
26	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 07/2002
14	oxidized low density lipoproteinIBA 08/2022 - 07/2003
12	Triglycerides (Triacylglycerol)IBA 04/2023 - 05/2002
12	LDL CholesterolIBA 08/2022 - 01/2006
12	CholesterolIBA 07/2017 - 01/2004
9	HDL CholesterolIBA 12/2022 - 01/2002
9	Phytanic AcidIBA 01/2017 - 03/2002
7	Fibric Acids (Fibrates)IBA 01/2020 - 12/2006
6	ISIS 304801IBA 04/2023 - 01/2016
6	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 01/2004
6	LDL Lipoproteins (beta Lipoproteins)IBA 12/2017 - 07/2003
6	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2014 - 02/2005
5	HDL LipoproteinsIBA 01/2020 - 11/2004
5	Proteins (Proteins, Gene)FDA Link 09/2013 - 03/2002
4	Antisense OligonucleotidesIBA 01/2020 - 04/2012
4	Lipoprotein(a)IBA 11/2017 - 01/2004
4	CreatinineIBA 09/2011 - 07/2003
3	Lipoproteins (Lipoprotein)IBA 12/2022 - 03/2002
3	Bile Acids and Salts (Bile Acids)IBA 08/2022 - 11/2010
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 05/2002
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2020 - 01/2004
3	evolocumabIBA 01/2018 - 11/2016
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2017 - 04/2012
3	Ezetimibe (Zetia)FDA Link 08/2013 - 07/2010
3	Simvastatin (Zocor)FDA LinkGeneric 07/2011 - 11/2009
3	Apolipoproteins B (ApoB)IBA 03/2006 - 05/2002
3	ApolipoproteinsIBA 03/2006 - 05/2002
2	Colesevelam Hydrochloride (Welchol)FDA Link 08/2022 - 11/2010
2	AcidsIBA 12/2019 - 08/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017 - 06/2009
2	Growth Hormone (Somatotropin)IBA 07/2017 - 05/2002
2	phytanoyl-coenzyme A (phytanoyl CoA)IBA 01/2017 - 02/2003
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017 - 02/2003
2	mipomersenIBA 01/2016 - 09/2013
2	Carrier Proteins (Binding Protein)IBA 04/2012 - 05/2002
2	Creatine Kinase (Creatine Phosphokinase)IBA 03/2012 - 03/2005
2	Biomarkers (Surrogate Marker)IBA 07/2011 - 01/2006
2	Atorvastatin (Lipitor)FDA Link 07/2010 - 01/2002
2	Peptides (Polypeptides)IBA 11/2009 - 11/2004
2	HomocysteineIBA 06/2007 - 07/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006 - 07/2003
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2004 - 07/2003
2	C-Reactive ProteinIBA 01/2004 - 07/2003
1	evinacumabIBA 12/2022
1	SphingolipidsIBA 01/2022
1	CeramidesIBA 01/2022

Therapy/Procedure

35	Therapeutics 01/2024 - 05/2002
5	Secondary Prevention 12/2015 - 12/2006
3	Drug Therapy (Chemotherapy) 07/2017 - 02/2010
3	Highly Active Antiretroviral Therapy (HAART) 01/2012 - 11/2005
2	Radiotherapy 07/2017 - 07/2014
1	Glycemic Control 08/2022